Alexandria Pharmaceuticals Auditor Issues Qualified Opinion on Annual Accounts

The auditor of Alexandria Pharmaceuticals and Chemical Industries has issued a qualified opinion on the company’s financial statements for the fiscal year ended June 30, 2026.

The opinion was set out in an auditor’s report addressed to the company’s shareholders. A qualified opinion signals reservations about specific aspects of the accounts, rather than an outright rejection of the financial statements as a whole.

The supplied headline also flags a fire-related insurance issue and questions involving SAIB Bank. However, the accompanying summary does not explain either matter or establish how it relates to the auditor’s qualification.

No details were provided on the financial impact of the auditor’s reservations or the company’s response. The full report would be needed to assess the grounds for the qualified opinion and their implications for shareholders.